Cargando…
Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
BACKGROUND: β Thalassemia is one of the most common groups of hereditary haemoglobinopathies. Affected people with thalassemia major are dependent on regular blood transfusion which on the long term leads to iron overload. Hepcidin is a peptide hormone and an important regulator of iron homeostasis,...
Autores principales: | Zarghamian, Parinaz, Azarkeivan, Azita, Arabkhazaeli, Ali, Mardani, Ahmad, Shahabi, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140315/ https://www.ncbi.nlm.nih.gov/pubmed/32268883 http://dx.doi.org/10.1186/s12881-020-01011-3 |
Ejemplares similares
-
Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017) -
Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017) -
Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017) -
Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022) -
Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
por: Alavi, Samin, et al.
Publicado: (2014)